STOCK TITAN

[SCHEDULE 13D/A] Cardlytics, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13D/A
Rhea-AI Filing Summary

CAS Investment Partners, Sosin Master and related entities report combined shared beneficial ownership of 5,198,067 shares of Cardlytics (CDLX), representing approximately 9.8% of the outstanding common stock based on 53,236,901 shares outstanding as of July 31, 2025. Sosin Master directly holds 3,198,584 shares (about 6.0%) and CSWR directly holds 1,999,483 shares (about 3.8%). The filing states the Sosin entities purchased shares in open market transactions funded primarily with working capital; aggregate purchase prices were approximately $88.6 million for Sosin Master and $65.0 million for CSWR. Reporting persons disclose shared voting and dispositive power only and note holdings of convertible notes with principal amounts of $13.74 million (Sosin Master) and $7.50 million (CSWR), which may be settled in cash or shares at the issuer’s option.

CAS Investment Partners, Sosin Master e entità correlate dichiarano una proprietà economica condivisa di 5.198.067 azioni di Cardlytics (CDLX), pari a circa il 9,8% del capitale sociale ordinario in circolazione, basato su 53.236.901 azioni in circolazione al 31 luglio 2025. Sosin Master detiene direttamente 3.198.584 azioni (circa il 6,0%) e CSWR detiene direttamente 1.999.483 azioni (circa il 3,8%). La comunicazione indica che le entità Sosin hanno acquistato azioni sul mercato aperto finanziandole principalmente con capitale operativo; i prezzi d'acquisto aggregati sono stati di circa 88,6 milioni di dollari per Sosin Master e 65,0 milioni di dollari per CSWR. I soggetti segnalanti dichiarano di avere solo poteri condivisi di voto e disposizione e riportano inoltre detenzioni di note convertibili con importi nominali di 13,74 milioni di dollari (Sosin Master) e 7,50 milioni di dollari (CSWR), che possono essere rimborsate in contanti o con azioni a discrezione dell'emittente.

CAS Investment Partners, Sosin Master y entidades relacionadas informan una propiedad económica compartida de 5.198.067 acciones de Cardlytics (CDLX), lo que representa aproximadamente el 9,8% del capital social ordinario en circulación, con base en 53.236.901 acciones en circulación a fecha 31 de julio de 2025. Sosin Master posee directamente 3.198.584 acciones (aprox. 6,0%) y CSWR posee directamente 1.999.483 acciones (aprox. 3,8%). La presentación indica que las entidades Sosin adquirieron acciones en transacciones de mercado abierto, financiadas principalmente con capital de trabajo; los precios de compra agregados fueron aproximadamente 88,6 millones de dólares para Sosin Master y 65,0 millones de dólares para CSWR. Las personas reportantes declaran tener únicamente poderes compartidos de voto y disposición y señalan además tenencias de pagarés convertibles por importes nominales de 13,74 millones de dólares (Sosin Master) y 7,50 millones de dólares (CSWR), que pueden liquidarse en efectivo o en acciones a elección del emisor.

CAS Investment Partners, Sosin Master 및 관련 법인들은 Cardlytics(CDLX) 주식 5,198,067주를 공동 실질 보유하고 있다고 보고했으며, 이는 2025년 7월 31일 기준 유통 보통주 53,236,901주를 기준으로 약 9.8%에 해당합니다. Sosin Master는 직접 3,198,584주(약 6.0%)를 보유하고 있으며 CSWR는 직접 1,999,483주(약 3.8%)를 보유하고 있습니다. 신고서에 따르면 Sosin 계열사는 주로 운전자본으로 자금을 조달하여 공개 시장에서 주식을 매수했으며, 합산 매입 금액은 Sosin Master가 약 8,860만 달러, CSWR가 약 6,500만 달러였습니다. 보고인은 공동 의결권 및 처분권만 보유하고 있음을 밝히며, 또한 발행자의 선택에 따라 현금 또는 주식으로 정산될 수 있는 원금 1,374만 달러(Sosin Master) 및 750만 달러(CSWR) 규모의 전환사채 보유를 공시했습니다.

CAS Investment Partners, Sosin Master et entités affiliées déclarent une propriété bénéficiaire partagée de 5 198 067 actions de Cardlytics (CDLX), soit environ 9,8 % du capital social ordinaire en circulation, sur la base de 53 236 901 actions en circulation au 31 juillet 2025. Sosin Master détient directement 3 198 584 actions (environ 6,0 %) et CSWR détient directement 1 999 483 actions (environ 3,8 %). Le dépôt indique que les entités Sosin ont acheté des actions sur le marché ouvert financées principalement par des capitaux d'exploitation ; les prix d'achat agrégés s'élèvent à environ 88,6 millions de dollars pour Sosin Master et 65,0 millions de dollars pour CSWR. Les personnes déclarantes précisent qu'elles n'exercent que des pouvoirs partagés de vote et de disposition et signalent également des avoirs en billets convertibles d'un montant nominal de 13,74 millions de dollars (Sosin Master) et 7,50 millions de dollars (CSWR), qui peuvent être réglés en espèces ou en actions à la discrétion de l'émetteur.

CAS Investment Partners, Sosin Master und verbundenen Gesellschaften melden eine gemeinsam wirtschaftlich gehaltene Beteiligung von 5.198.067 Aktien an Cardlytics (CDLX), was etwa 9,8% des ausstehenden Stammkapitals entspricht, basierend auf 53.236.901 ausstehenden Aktien zum 31. Juli 2025. Sosin Master hält direkt 3.198.584 Aktien (ca. 6,0%) und CSWR hält direkt 1.999.483 Aktien (ca. 3,8%). Die Meldung gibt an, dass die Sosin-Gesellschaften Aktien in offenen Markttransaktionen erworben haben, die hauptsächlich mit Betriebskapital finanziert wurden; die kumulierten Kaufpreise beliefen sich auf etwa 88,6 Millionen US-Dollar für Sosin Master und 65,0 Millionen US-Dollar für CSWR. Die meldepflichtigen Personen geben an, nur geteilte Stimm- und Verfügungsrechte zu haben, und weisen zudem Bestände an wandelbaren Schuldverschreibungen mit Nennbeträgen von 13,74 Millionen US-Dollar (Sosin Master) bzw. 7,50 Millionen US-Dollar (CSWR) aus, die nach Wahl des Emittenten bar oder in Aktien beglichen werden können.

Positive
  • Combined stake of 5,198,067 shares representing approximately 9.8% of CDLX outstanding is a material ownership position
  • Sosin Master directly owns 3,198,584 shares (~6.0%) and CSWR directly owns 1,999,483 shares (~3.8%)
  • Aggregate purchase prices disclosed: approximately $88.62 million for Sosin Master and $65.03 million for CSWR, showing clear capital commitment
Negative
  • No sole voting or dispositive power reported — all voting and disposition is shared, indicating no unilateral control
  • Convertible notes held are not treated as beneficially owned because the issuer may settle conversions in cash, shares, or a combination, creating contingent exposure

Insights

TL;DR: Combined ownership of ~9.8% of CDLX via open-market purchases funded with working capital; holdings include convertible notes.

The disclosed positions are material in size relative to the 53.24 million shares outstanding, with Sosin Master holding ~6.0% and CSWR ~3.8%. The filing documents aggregate cash outlays of approximately $153.6 million across the two funds, indicating meaningful capital commitment. The reporting parties assert only shared voting and dispositive power, not sole control. The convertible notes positions create potential future equity exposure but are not treated as beneficially owned due to issuer conversion settlement discretion.

TL;DR: A near-10% shared stake is significant for governance dynamics, though no sole voting control is claimed.

The disclosure signals an influential minority ownership block that could affect shareholder votes or negotiations, yet the reporting persons explicitly report no sole voting or dispositive power. That distinction limits immediate unilateral control but preserves the potential for coordinated action among related entities. The pro rata distributions and recent open-market activity are documented, and the presence of notes convertible at the issuer’s option warrants attention as potential dilutive exposure depending on future settlement choices.

CAS Investment Partners, Sosin Master e entità correlate dichiarano una proprietà economica condivisa di 5.198.067 azioni di Cardlytics (CDLX), pari a circa il 9,8% del capitale sociale ordinario in circolazione, basato su 53.236.901 azioni in circolazione al 31 luglio 2025. Sosin Master detiene direttamente 3.198.584 azioni (circa il 6,0%) e CSWR detiene direttamente 1.999.483 azioni (circa il 3,8%). La comunicazione indica che le entità Sosin hanno acquistato azioni sul mercato aperto finanziandole principalmente con capitale operativo; i prezzi d'acquisto aggregati sono stati di circa 88,6 milioni di dollari per Sosin Master e 65,0 milioni di dollari per CSWR. I soggetti segnalanti dichiarano di avere solo poteri condivisi di voto e disposizione e riportano inoltre detenzioni di note convertibili con importi nominali di 13,74 milioni di dollari (Sosin Master) e 7,50 milioni di dollari (CSWR), che possono essere rimborsate in contanti o con azioni a discrezione dell'emittente.

CAS Investment Partners, Sosin Master y entidades relacionadas informan una propiedad económica compartida de 5.198.067 acciones de Cardlytics (CDLX), lo que representa aproximadamente el 9,8% del capital social ordinario en circulación, con base en 53.236.901 acciones en circulación a fecha 31 de julio de 2025. Sosin Master posee directamente 3.198.584 acciones (aprox. 6,0%) y CSWR posee directamente 1.999.483 acciones (aprox. 3,8%). La presentación indica que las entidades Sosin adquirieron acciones en transacciones de mercado abierto, financiadas principalmente con capital de trabajo; los precios de compra agregados fueron aproximadamente 88,6 millones de dólares para Sosin Master y 65,0 millones de dólares para CSWR. Las personas reportantes declaran tener únicamente poderes compartidos de voto y disposición y señalan además tenencias de pagarés convertibles por importes nominales de 13,74 millones de dólares (Sosin Master) y 7,50 millones de dólares (CSWR), que pueden liquidarse en efectivo o en acciones a elección del emisor.

CAS Investment Partners, Sosin Master 및 관련 법인들은 Cardlytics(CDLX) 주식 5,198,067주를 공동 실질 보유하고 있다고 보고했으며, 이는 2025년 7월 31일 기준 유통 보통주 53,236,901주를 기준으로 약 9.8%에 해당합니다. Sosin Master는 직접 3,198,584주(약 6.0%)를 보유하고 있으며 CSWR는 직접 1,999,483주(약 3.8%)를 보유하고 있습니다. 신고서에 따르면 Sosin 계열사는 주로 운전자본으로 자금을 조달하여 공개 시장에서 주식을 매수했으며, 합산 매입 금액은 Sosin Master가 약 8,860만 달러, CSWR가 약 6,500만 달러였습니다. 보고인은 공동 의결권 및 처분권만 보유하고 있음을 밝히며, 또한 발행자의 선택에 따라 현금 또는 주식으로 정산될 수 있는 원금 1,374만 달러(Sosin Master) 및 750만 달러(CSWR) 규모의 전환사채 보유를 공시했습니다.

CAS Investment Partners, Sosin Master et entités affiliées déclarent une propriété bénéficiaire partagée de 5 198 067 actions de Cardlytics (CDLX), soit environ 9,8 % du capital social ordinaire en circulation, sur la base de 53 236 901 actions en circulation au 31 juillet 2025. Sosin Master détient directement 3 198 584 actions (environ 6,0 %) et CSWR détient directement 1 999 483 actions (environ 3,8 %). Le dépôt indique que les entités Sosin ont acheté des actions sur le marché ouvert financées principalement par des capitaux d'exploitation ; les prix d'achat agrégés s'élèvent à environ 88,6 millions de dollars pour Sosin Master et 65,0 millions de dollars pour CSWR. Les personnes déclarantes précisent qu'elles n'exercent que des pouvoirs partagés de vote et de disposition et signalent également des avoirs en billets convertibles d'un montant nominal de 13,74 millions de dollars (Sosin Master) et 7,50 millions de dollars (CSWR), qui peuvent être réglés en espèces ou en actions à la discrétion de l'émetteur.

CAS Investment Partners, Sosin Master und verbundenen Gesellschaften melden eine gemeinsam wirtschaftlich gehaltene Beteiligung von 5.198.067 Aktien an Cardlytics (CDLX), was etwa 9,8% des ausstehenden Stammkapitals entspricht, basierend auf 53.236.901 ausstehenden Aktien zum 31. Juli 2025. Sosin Master hält direkt 3.198.584 Aktien (ca. 6,0%) und CSWR hält direkt 1.999.483 Aktien (ca. 3,8%). Die Meldung gibt an, dass die Sosin-Gesellschaften Aktien in offenen Markttransaktionen erworben haben, die hauptsächlich mit Betriebskapital finanziert wurden; die kumulierten Kaufpreise beliefen sich auf etwa 88,6 Millionen US-Dollar für Sosin Master und 65,0 Millionen US-Dollar für CSWR. Die meldepflichtigen Personen geben an, nur geteilte Stimm- und Verfügungsrechte zu haben, und weisen zudem Bestände an wandelbaren Schuldverschreibungen mit Nennbeträgen von 13,74 Millionen US-Dollar (Sosin Master) bzw. 7,50 Millionen US-Dollar (CSWR) aus, die nach Wahl des Emittenten bar oder in Aktien beglichen werden können.






If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D


CAS Investment Partners, LLC
Signature:/s/ Clifford Sosin
Name/Title:Clifford Sosin, Managing Member
Date:08/20/2025
SOSIN MASTER, LP
Signature:/s/ Clifford Sosin
Name/Title:Clifford Sosin, Managing Member of CAS Investment Partners, LLC, Investment Adviser of Sosin Master, LP
Date:08/20/2025
CSWR PARTNERS, LP
Signature:/s/ Clifford Sosin
Name/Title:Clifford Sosin, Managing Member of CAS Investment Partners, LLC, Investment Adviser of CSWR Partners, LP
Date:08/20/2025
SOSIN LLC
Signature:/s/ Clifford Sosin
Name/Title:Clifford Sosin, Managing Member of CAS Investment Partners, LLC, Investment Adviser of Sosin Master, LP and CSWR Partners, LP
Date:08/20/2025
SOSIN CLIFFORD
Signature:/s/ Clifford Sosin
Name/Title:Clifford Sosin
Date:08/20/2025

FAQ

How many Cardlytics (CDLX) shares do the Sosin entities report owning?

The reporting persons disclose beneficial ownership of 5,198,067 shares in the aggregate, representing approximately 9.8% of outstanding shares.

What are the individual holdings of Sosin Master and CSWR in CDLX?

As of August 19, 2025, Sosin Master holds 3,198,584 shares (~6.0%) and CSWR holds 1,999,483 shares (~3.8%).

How were the purchases funded according to the filing?

The filing states purchases by Sosin Master and CSWR were made with working capital, which may include margin loans in the ordinary course of business.

What cash amounts did the reporting persons pay to acquire their CDLX positions?

The aggregate purchase price disclosed is approximately $88,620,705 for Sosin Master and $65,026,672 for CSWR, including brokerage commissions.

Do the reporting persons have sole voting or dispositive power over these shares?

No. The filing reports 0 sole voting power and 0 sole dispositive power; all reported voting and dispositive powers are shared.

Are there convertible notes mentioned in the filing and who holds them?

Yes. Sosin Master directly holds $13,741,366 principal amount of the notes and CSWR directly holds $7,501,634 principal amount of the notes; conversions may be settled in cash, shares, or both at the issuer’s option.
Cardlytics

NASDAQ:CDLX

CDLX Rankings

CDLX Latest News

CDLX Latest SEC Filings

CDLX Stock Data

55.90M
51.80M
2.71%
46.6%
12.09%
Advertising Agencies
Services-computer Programming, Data Processing, Etc.
Link
United States
ATLANTA